Jenburkt Pharmaceuticals Ltd — Important, 10-07-2026: Company Update

Jenburkt Pharmaceuticals has submitted a compliance certificate from its Registrar and Transfer Agent for the quarter ended 30th June, 2026. This confirms the company's adherence to regulatory requirements regarding share dematerialization. The Registrar verified that securities received for dematerialization were processed, confirmed with depositories, and listed on the stock exchange. Physical certificates were cancelled and registered correctly within the stipulated timeframe. This update assures investors that the company's share transfer and record-keeping processes are managed appropriately.